Literature DB >> 16179780

Population-based screening for family history of end-stage renal disease among incident dialysis patients.

Barry I Freedman1, Nataliya V Volkova, Scott G Satko, Jenna Krisher, Claudine Jurkovitz, J Michael Soucie, William M McClellan.   

Abstract

BACKGROUND: We determined the familial aggregation of end-stage renal disease (ESRD) in a large, population-based sample of incident ESRD cases to assess the feasibility of developing a targeted screening and prevention program directed at members of families at high risk for kidney disease.
METHODS: Between January 1, 1995, and December 31, 2003, incident dialysis patients in ESRD Network 6 facilities were asked to complete a voluntary questionnaire on family history (FH) of ESRD. Cases with ESRD attributed to Mendelian diseases or urologic causes were excluded. FH was considered present if first- or second-degree relatives had ESRD. De-identified FH data were collated with demographic data at dialysis initiation.
RESULTS: More than 46% of eligible patients (25,883/55,929) provided FH information and 22.8% (5,901/25,883) of these reported having a FH of ESRD. FH of ESRD was positively associated with female gender, earlier age at ESRD onset, and primary cause of ESRD, and negatively associated with white race. FH associations with age, race, gender, and primary cause of renal failure remained statistically significant after simultaneous adjustment in a multivariate logistic regression model.
CONCLUSIONS: Approximately 23% of incident dialysis patients have close relatives with ESRD. Far more are likely to have relatives with clinically silent proteinuria or chronic kidney disease (CKD), both risk factors for future cardiovascular events and ESRD. Physicians caring for patients with CKD should be aware of the marked familial aggregation of ESRD and consider focusing screening efforts on high-risk family members in an attempt to slow the exponential growth rate of kidney disease.

Entities:  

Mesh:

Year:  2005        PMID: 16179780     DOI: 10.1159/000088491

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  37 in total

1.  Hypertensive renal injury is associated with gene variation affecting immune signaling.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Yaming Zhu; Manuel L Gonzalez-Garay; Scott E Wenderfer; Peter A Doris
Journal:  Circ Cardiovasc Genet       Date:  2014-11-03

2.  Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Rachel E Patzer; Brian D Bradbury; Leslie A McClure; Britt B Newsome; George Howard
Journal:  Am J Kidney Dis       Date:  2011-11-10       Impact factor: 8.860

3.  The new era of APOL1-associated glomerulosclerosis.

Authors:  Barry I Freedman; Carl D Langefeld
Journal:  Nephrol Dial Transplant       Date:  2012-02-02       Impact factor: 5.992

Review 4.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

5.  Personalized medicine in chronic kidney disease by detection of monogenic mutations.

Authors:  Dervla M Connaughton; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

Review 6.  Insights into the genetic architecture of diabetic nephropathy.

Authors:  Nicholette D Palmer; Barry I Freedman
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 7.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

Review 8.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

Review 9.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

10.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.